Schizophrenia is a devastating illness, with unknown pathophysiology, that affects 1% of the world's population. The experiments in the following revised proposal will focus on the basal ganglia and dopamine (DA) pathology in schizophrenia (SA1) and relate these changes to those occurring in rats treated with antipsychotic drugs (APDs) (SA2). Our preliminary data shows abnormalities in morphology of DAergic neurons in the substantia nigra (SN) and in the number of TH+ striatal synapses in electron microscopic (EM) studies of postmortem tissue from subjects with schizophrenia (SZ), similar structural changes and a decrease in number of TH+ cells in rats treated with APD. SA1 tests the hypothesis that the DA system is perturbed in the basal ganglia of SZ, using tissue from normal controls, SZ treated with typical or atypical APDs or off-drug. SA2 tests the hypothesis that anatomical changes observed in SN and ventral tegmental area (VTA) of SZ are the results, in part, of APDs, and will determine the contributing physiological mechanisms. In both aims, we will determine if the morphological alterations seen will show regional variations that are consistent with the differential effects of typical and atypical APDs on the activity of midbrain DA neurons. In this revision, we have modified the EM analysis of the SN and added 3 parallel experiments in both the human tissue and rats (treated with haloperidol or clozapine or controls). In SA1a the synaptic organization of DA labeled profiles will be analyzed in the human striatum at the EM level. In SA1b & SA2a, the number and size of Nissl stained, and TH+ cells double labeled with the DA transporter (DAT), or a selective marker of DA cells, SK3, will be determined using stereological methods in the SN/VTA. In SA1c & SA2b at the EM level, the integrity of subcellular organelles and the synaptic organization to the TH+ neurons (also labeled with DAT or SK3) will be studied. Using in situ hybridization SA1d & SA2e will determine if TH synthesis is affected at the level of transcription. SA1c & SA2d will determine if cytoskeletal proteins are upregulated. SA1f & SA2e will determine if the loss of TH in neurons is due to changes at the translational level by using Western blot analysis. SA2f will study the time course of the anatomical changes observed during APD treatment and relate these changes to the development of depolarization (DP) block. SA2g tests the hypothesis that morphological alterations in SN/VTA neurons will not occur in rats treated with APD if DP block is prevented (with a unilateral striatal lesion).

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH066123-03
Application #
6879717
Study Section
Special Emphasis Panel (ZRG1-BDCN-2 (01))
Program Officer
Meinecke, Douglas L
Project Start
2003-04-01
Project End
2008-01-31
Budget Start
2005-02-01
Budget End
2006-01-31
Support Year
3
Fiscal Year
2005
Total Cost
$334,125
Indirect Cost
Name
University of Maryland Baltimore
Department
Psychiatry
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Roberts, Rosalinda C (2017) Postmortem studies on mitochondria in schizophrenia. Schizophr Res 187:17-25
Walker, Courtney K; Roche, Joy K; Sinha, Vidushi et al. (2017) Substantia nigra ultrastructural pathology in schizophrenia. Schizophr Res :
Schoonover, Kirsten E; McCollum, Lesley A; Roberts, Rosalinda C (2017) Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra. Neuropsychopharmacology 42:540-550
McCollum, Lesley A; McCullumsmith, Robert E; Roberts, Rosalinda C (2016) Tyrosine hydroxylase localization in the nucleus accumbens in schizophrenia. Brain Struct Funct 221:4451-4458
Rice, Matthew W; Roberts, Rosalinda C; Melendez-Ferro, Miguel et al. (2016) Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia. Brain Struct Funct 221:185-201
McCollum, Lesley A; Roberts, Rosalinda C (2015) Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters. Schizophr Res 169:369-373
McCollum, Lesley A; Walker, Courtney K; Roche, Joy K et al. (2015) Elevated Excitatory Input to the Nucleus Accumbens in Schizophrenia: A Postmortem Ultrastructural Study. Schizophr Bull 41:1123-32
McCollum, L A; Roberts, R C (2014) Ultrastructural localization of tyrosine hydroxylase in tree shrew nucleus accumbens core and shell. Neuroscience 271:23-34
Rice, Matthew W; Smith, Kristen L; Roberts, Rosalinda C et al. (2014) Assessment of cytochrome C oxidase dysfunction in the substantia nigra/ventral tegmental area in schizophrenia. PLoS One 9:e100054
Melendez-Ferro, Miguel; Rice, Matthew W; Roberts, Rosalinda C et al. (2013) An accurate method for the quantification of cytochrome C oxidase in tissue sections. J Neurosci Methods 214:156-62

Showing the most recent 10 out of 27 publications